Letteratura

Asthma

Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis CA. Immunologic mechanisms in asthma. Seminars in Immunology [Internet]. 2019 Dec;46:101333. Available from: http://dx.doi.org/10.1016/j.smim.2019.101333

Wang E, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, et al. Characterization of Severe Asthma Worldwide. Chest [Internet]. 2020 Apr;157(4):790–804. Available from: http://dx.doi.org/10.1016/j.chest.2019.10.053

Busse WW. Biological treatments for severe asthma: A major advance in asthma care. Allergology International [Internet]. 2019 Apr;68(2):158–66. Available from: http://dx.doi.org/10.1016/j.alit.2019.01.004

Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults. JAMA [Internet]. 2020 Dec 8;324(22):2301. Available from: http://dx.doi.org/10.1001/jama.2020.21974

Lau A, Tarlo SM. Update on the Management of Occupational Asthma and Work-Exacerbated Asthma. Allergy, Asthma & Immunology Research [Internet]. 2019;11(2):188. Available from: http://dx.doi.org/10.4168/aair.2019.11.2.188

Abdullah K, Zhu J, Gershon A, Dell S, To T. Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study. European Respiratory Journal [Internet]. 2019 Nov 26;55(2):1901335. Available from: http://dx.doi.org/10.1183/13993003.01335-2019

Papi A, Blasi F, Canonica GW, Morandi L, Richeldi L, Rossi A. Treatment strategies for asthma: reshaping the concept of asthma management. Allergy, Asthma & Clinical Immunology [Internet]. 2020 Aug 15;16(1). Available from: http://dx.doi.org/10.1186/s13223-020-00472-8

Neffen H, Chahuàn M, Hernández DD, Vallejo-Perez E, Bolivar F, Sánchez MH, et al. Key factors associated with uncontrolled asthma – the Asthma Control in Latin America Study. Journal of Asthma [Internet]. 2019 Mar 27;57(2):113–22. Available from: http://dx.doi.org/10.1080/02770903.2018.1553050

Senna G, Latorre M, Bugiani M, Caminati M, Heffler E, Morrone D, et al. Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI. Allergy, Asthma & Immunology Research [Internet]. 2021;13(2):219. Available from: http://dx.doi.org/10.4168/aair.2021.13.2.219

Menzies-Gow A, Szefler SJ, Busse WW. The Relationship of Asthma Biologics to Remission for Asthma. The Journal of Allergy and Clinical Immunology: In Practice [Internet]. 2021 Mar;9(3):1090–8. Available from: http://dx.doi.org/10.1016/j.jaip.2020.10.035

Chronic obstructive pulmonary disease (COPD)

Labaki WW, Rosenberg SR. Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine [Internet]. 2020 Aug 4;173(3):ITC17–32. Available from: http://dx.doi.org/10.7326/aitc202008040

Agustí A, Hogg JC. Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. Drazen JM, editor. New England Journal of Medicine [Internet]. 2019 Sep 26;381(13):1248–56. Available from: http://dx.doi.org/10.1056/nejmra1900475

Celli BR, Wedzicha JA. Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease. Drazen JM, editor. New England Journal of Medicine [Internet]. 2019 Sep 26;381(13):1257–66. Available from: http://dx.doi.org/10.1056/nejmra1900500

Lacasse Y, Sériès F, Corbeil F, Baltzan M, Paradis B, Simão P, et al. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine [Internet]. 2020 Sep 17;383(12):1129–38. Available from: http://dx.doi.org/10.1056/nejmoa2013219

Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease [Internet]. 2020 Feb;Volume 15:439–60. Available from: http://dx.doi.org/10.2147/copd.s234942

Young AL, Bragman FJS, Rangelov B, Han MK, Galbán CJ, Lynch DA, et al. Disease Progression Modeling in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 Feb 1;201(3):294–302. Available from: http://dx.doi.org/10.1164/rccm.201908-1600oc

Bhatt SP, Washko GR, Hoffman EA, Newell JD, Bodduluri S, Diaz AA, et al. Imaging Advances in Chronic Obstructive Pulmonary Disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study. American Journal of Respiratory and Critical Care Medicine [Internet]. 2019 Feb 1;199(3):286–301. Available from: http://dx.doi.org/10.1164/rccm.201807-1351so

Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nature Communications [Internet]. 2020 Nov 18;11(1). Available from: http://dx.doi.org/10.1038/s41467-020-19701-0

Stockley RA, Halpin DMG, Celli BR, Singh D. Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation. American Journal of Respiratory and Critical Care Medicine [Internet]. 2019 May 15;199(10):1195–204. Available from: http://dx.doi.org/10.1164/rccm.201810-1860so

Martinez FJ, Agusti A, Celli BR, Han MK, Allinson JP, Bhatt SP, et al. Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward. American Journal of Respiratory and Critical Care Medicine [Internet]. 2022 Feb 1;205(3):275–87. Available from: http://dx.doi.org/10.1164/rccm.202107-1663so

Idiopathic pulmonary fibrosis

Moss BJ, Ryter SW, Rosas IO. Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. Annual Review of Pathology: Mechanisms of Disease [Internet]. 2022 Jan 24;17(1):515–46. Available from: http://dx.doi.org/10.1146/annurev-pathol-042320-030240

Allen RJ, Guillen-Guio B, Oldham JM, Ma S-F, Dressen A, Paynton ML, et al. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 Mar 1;201(5):564–74. Available from: http://dx.doi.org/10.1164/rccm.201905-1017oc

Spagnolo P, Kropski JA, Jones MG, Lee JS, Rossi G, Karampitsakos T, et al. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development. Pharmacology & Therapeutics [Internet]. 2021 Jun;222:107798. Available from: http://dx.doi.org/10.1016/j.pharmthera.2020.107798

Morse C, Tabib T, Sembrat J, Buschur KL, Bittar HT, Valenzi E, et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. European Respiratory Journal [Internet]. 2019 Jun 20;54(2):1802441. Available from: http://dx.doi.org/10.1183/13993003.02441-2018

Albert RK, Schwartz DA. Revealing the Secrets of Idiopathic Pulmonary Fibrosis. Phimister EG, editor. New England Journal of Medicine [Internet]. 2019 Jan 3;380(1):94–6. Available from: http://dx.doi.org/10.1056/nejmcibr1811639

Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine [Internet]. 2022 May 1;205(9):e18–47. Available from: http://dx.doi.org/10.1164/rccm.202202-0399st

Phan THG, Paliogiannis P, Nasrallah GK, Giordo R, Eid AH, Fois AG, et al. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cellular and Molecular Life Sciences [Internet]. 2020 Nov 17;78(5):2031–57. Available from: http://dx.doi.org/10.1007/s00018-020-03693-7

Shenderov K, Collins SL, Powell JD, Horton MR. Immune dysregulation as a driver of idiopathic pulmonary fibrosis. Journal of Clinical Investigation [Internet]. 2021 Jan 19;131(2). Available from: http://dx.doi.org/10.1172/jci143226

Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, et al. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. New England Journal of Medicine [Internet]. 2022 Jun 9;386(23):2178–87. Available from: http://dx.doi.org/10.1056/nejmoa2201737

Ng B, Dong J, D’Agostino G, Viswanathan S, Widjaja AA, Lim W-W, et al. Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis. Science Translational Medicine [Internet]. 2019 Sep 25;11(511). Available from: http://dx.doi.org/10.1126/scitranslmed.aaw1237

Interstitial lung disease

Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A, et al. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. New England Journal of Medicine [Internet]. 2021 Jan 28;384(4):325–34. Available from: http://dx.doi.org/10.1056/nejmoa2008470

Hoffmann-Vold A-M, Allanore Y, Alves M, Brunborg C, Airó P, Ananieva LP, et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Annals of the Rheumatic Diseases [Internet]. 2020 Sep 28;80(2):219–27. Available from: http://dx.doi.org/10.1136/annrheumdis-2020-217455

Chen Z, Wang X, Ye S. Tofacitinib in Amyopathic Dermatomyositis–Associated Interstitial Lung Disease. New England Journal of Medicine [Internet]. 2019 Jul 18;381(3):291–3. Available from: http://dx.doi.org/10.1056/nejmc1900045

Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. The Lancet Respiratory Medicine [Internet]. 2020 Mar;8(3):304–20. Available from: http://dx.doi.org/10.1016/s2213-2600(19)30480-1

Wong AW, Ryerson CJ, Guler SA. Progression of fibrosing interstitial lung disease. Respiratory Research [Internet]. 2020 Jan 29;21(1). Available from: http://dx.doi.org/10.1186/s12931-020-1296-3

Hunninghake GM, Quesada-Arias LD, Carmichael NE, Martinez Manzano JM, Poli De Frías S, Baumgartner MA, et al. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 May 15;201(10):1240–8. Available from: http://dx.doi.org/10.1164/rccm.201908-1571oc

Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, et al. Predicting outcomes in rheumatoid arthritis related interstitial lung disease. European Respiratory Journal [Internet]. 2018 Nov 28;53(1):1800869. Available from: http://dx.doi.org/10.1183/13993003.00869-2018

Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine [Internet]. 2020 Mar 15;201(6):650–60. Available from: http://dx.doi.org/10.1164/rccm.201903-0563ci

Roofeh D, Lin CJF, Goldin J, Kim GH, Furst DE, Denton CP, et al. Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease. Arthritis & Rheumatology [Internet]. 2021 May 25;73(7):1301–10. Available from: http://dx.doi.org/10.1002/art.41668

Kapnadak SG, Raghu G. Lung transplantation for interstitial lung disease. European Respiratory Review [Internet]. 2021 Aug 3;30(161):210017. Available from: http://dx.doi.org/10.1183/16000617.0017-2021

Pneumoconioses

Robinson C. Pneumoconioses. Chapman SJ, Robinson GV, Shrimanker R, Turnbull CD, Wrightson JM, editors. Oxford Handbook of Respiratory Medicine [Internet]. 2021 Apr;425–34. Available from: http://dx.doi.org/10.1093/med/9780198837114.003.0036

Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016. Occupational and Environmental Medicine [Internet]. 2020 Feb 13;77(3):142–50. Available from: http://dx.doi.org/10.1136/oemed-2019-106013

Reid PT. Pneumoconioses. Shah PL, editor. Oxford Textbook of Medicine [Internet]. 2020 Mar;4219-C18.13.P116. Available from: http://dx.doi.org/10.1093/med/9780198746690.003.0420

Nogami S, J‐P NA, Nogami M, Matsui T, Ngatu NR, Tamura T, et al. Radiographic diagnosis of Pneumoconioses by AIR Pneumo‐trained physicians: Comparison with low‐dose thin‐slice computed tomography. Journal of Occupational Health [Internet]. 2020 Jan;62(1). Available from: http://dx.doi.org/10.1002/1348-9585.12141

Perlman DM, Maier LA. Occupational Lung Disease. Medical Clinics of North America [Internet]. 2019 May;103(3):535–48. Available from: http://dx.doi.org/10.1016/j.mcna.2018.12.012

Bell JL, Mazurek JM. Trends in Pneumoconiosis Deaths — United States, 1999–2018. MMWR Morbidity and Mortality Weekly Report [Internet]. 2020 Jun 12;69(23):693–8. Available from: http://dx.doi.org/10.15585/mmwr.mm6923a1

Farver C, Ghosh S, Gildea T, Sturgis CD. Pneumoconioses. Pulmonary Disease [Internet]. 2020;223–34. Available from: http://dx.doi.org/10.1007/978-3-030-47598-7_16

Blanc PD, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, et al. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. American Journal of Respiratory and Critical Care Medicine [Internet]. 2019 Jun 1;199(11):1312–34. Available from: http://dx.doi.org/10.1164/rccm.201904-0717st

Kurth L, Halldin C, Laney AS, Blackley DJ. Causes of death among Federal Black Lung Benefits Program beneficiaries enrolled in Medicare, 1999–2016. American Journal of Industrial Medicine [Internet]. 2020 Sep 11;63(11):973–9. Available from: http://dx.doi.org/10.1002/ajim.23176

Morimoto Y. Progress in educational program for diagnosis of occupational respiratory disease in Japan ‐Activity of Asian Intensive Reader of Pneumoconioses (AIR Pneumo)‐. Journal of Occupational Health [Internet]. 2020 Jan;62(1). Available from: http://dx.doi.org/10.1002/1348-9585.12156

Pulmonary hypertension

Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, et al. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. New England Journal of Medicine [Internet]. 2021 Apr 1;384(13):1204–15. Available from: http://dx.doi.org/10.1056/nejmoa2024277

Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. European Respiratory Journal [Internet]. 2019 Jan;53(1):1801913. Available from: http://dx.doi.org/10.1183/13993003.01913-2018

Delcroix M, Torbicki A, Gopalan D, Sitbon O, Klok FA, Lang I, et al. ERS statement on chronic thromboembolic pulmonary hypertension. European Respiratory Journal [Internet]. 2020 Dec 17;57(6):2002828. Available from: http://dx.doi.org/10.1183/13993003.02828-2020

Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. European Respiratory Journal [Internet]. 2019 Jan;53(1):1801904. Available from: http://dx.doi.org/10.1183/13993003.01904-2018

Savale L, Guimas M, Ebstein N, Fertin M, Jevnikar M, Renard S, et al. Portopulmonary hypertension in the current era of pulmonary hypertension management. Journal of Hepatology [Internet]. 2020 Jul;73(1):130–9. Available from: http://dx.doi.org/10.1016/j.jhep.2020.02.021

Vachiéry J-L, Tedford RJ, Rosenkranz S, Palazzini M, Lang I, Guazzi M, et al. Pulmonary hypertension due to left heart disease. European Respiratory Journal [Internet]. 2019 Jan;53(1):1801897. Available from: http://dx.doi.org/10.1183/13993003.01897-2018

Xu W, Janocha AJ, Erzurum SC. Metabolism in Pulmonary Hypertension. Annual Review of Physiology [Internet]. 2021 Feb 10;83(1):551–76. Available from: http://dx.doi.org/10.1146/annurev-physiol-031620-123956

Humbert M, Farber HW, Ghofrani H-A, Benza RL, Busse D, Meier C, et al. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. European Respiratory Journal [Internet]. 2019 Mar 28;53(6):1802004. Available from: http://dx.doi.org/10.1183/13993003.02004-2018

Klok FA, Couturaud F, Delcroix M, Humbert M. Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. European Respiratory Journal [Internet]. 2020 Mar 17;55(6):2000189. Available from: http://dx.doi.org/10.1183/13993003.00189-2020

Papamatheakis DG, Poch DS, Fernandes TM, Kerr KM, Kim NH, Fedullo PF. Chronic Thromboembolic Pulmonary Hypertension. Journal of the American College of Cardiology [Internet]. 2020 Nov;76(18):2155–69. Available from: http://dx.doi.org/10.1016/j.jacc.2020.08.074

Pulmonary sarcoidosis

Thillai M, Atkins CP, Crawshaw A, Hart SP, Ho L-P, Kouranos V, et al. BTS Clinical Statement on pulmonary sarcoidosis. Thorax [Internet]. 2020 Dec 2;76(1):4–20. Available from: http://dx.doi.org/10.1136/thoraxjnl-2019-214348

Trivieri MG, Spagnolo P, Birnie D, Liu P, Drake W, Kovacic JC, et al. Challenges in Cardiac and Pulmonary Sarcoidosis. Journal of the American College of Cardiology [Internet]. 2020 Oct;76(16):1878–901. Available from: http://dx.doi.org/10.1016/j.jacc.2020.08.042

Gupta R, Judson MA, Baughman RP. Management of Advanced Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine [Internet]. 2022 Mar 1;205(5):495–506. Available from: http://dx.doi.org/10.1164/rccm.202106-1366ci

Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. European Respiratory Review [Internet]. 2020 Mar 20;29(155):190146. Available from: http://dx.doi.org/10.1183/16000617.0146-2019

Gupta R, Baughman RP. Advanced Pulmonary Sarcoidosis. Seminars in Respiratory and Critical Care Medicine [Internet]. 2020 Aug 10;41(05):700–15. Available from: http://dx.doi.org/10.1055/s-0040-1709495

Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R, et al. Diagnosis and Treatment of Pulmonary Sarcoidosis. JAMA [Internet]. 2022 Mar 1;327(9):856. Available from: http://dx.doi.org/10.1001/jama.2022.1570

Jeny F, Uzunhan Y, Lacroix M, Gille T, Brillet P-Y, Nardi A, et al. Predictors of mortality in fibrosing pulmonary sarcoidosis. Respiratory Medicine [Internet]. 2020 Aug;169:105997. Available from: http://dx.doi.org/10.1016/j.rmed.2020.105997

Kouranos V, Ward S, Kokosi MA, Castillo D, Chua F, Judge EP, et al. Mixed Ventilatory Defects in Pulmonary Sarcoidosis. Chest [Internet]. 2020 Nov;158(5):2007–14. Available from: http://dx.doi.org/10.1016/j.chest.2020.04.074

Greaves SA, Atif SM, Fontenot AP. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease. Frontiers in Immunology [Internet]. 2020 Mar 18;11. Available from: http://dx.doi.org/10.3389/fimmu.2020.00474

Huitema MP, Mathijssen H, Mager JJ, Snijder RJ, Grutters JC, Post MC. Sarcoidosis-Associated Pulmonary Hypertension. Seminars in Respiratory and Critical Care Medicine [Internet]. 2020 Aug 10;41(05):659–72. Available from: http://dx.doi.org/10.1055/s-0040-1713615

Respiratory distress syndrome

Barrot L, Asfar P, Mauny F, Winiszewski H, Montini F, Badie J, et al. Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome. New England Journal of Medicine [Internet]. 2020 Mar 12;382(11):999–1008. Available from: http://dx.doi.org/10.1056/nejmoa1916431

Middleton EA, He X-Y, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood [Internet]. 2020 Sep 3;136(10):1169–79. Available from: http://dx.doi.org/10.1182/blood.2020007008

Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. New England Journal of Medicine [Internet]. 2019 May 23;380(21):1997–2008. Available from: http://dx.doi.org/10.1056/nejmoa1901686

Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. New England Journal of Medicine [Internet]. 2019 Aug 22;381(8):785–8. Available from: http://dx.doi.org/10.1056/nejmc1908874

Spinelli E, Mauri T, Beitler JR, Pesenti A, Brodie D. Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions. Intensive Care Medicine [Internet]. 2020 Feb 3;46(4):606–18. Available from: http://dx.doi.org/10.1007/s00134-020-05942-6

Papazian L, Aubron C, Brochard L, Chiche J-D, Combes A, Dreyfuss D, et al. Formal guidelines: management of acute respiratory distress syndrome. Annals of Intensive Care [Internet]. 2019 Jun 13;9(1). Available from: http://dx.doi.org/10.1186/s13613-019-0540-9

Huppert L, Matthay M, Ware L. Pathogenesis of Acute Respiratory Distress Syndrome. Seminars in Respiratory and Critical Care Medicine [Internet]. 2019 Feb;40(01):031–9. Available from: http://dx.doi.org/10.1055/s-0039-1683996

Matthay MA, Arabi YM, Siegel ER, Ware LB, Bos LDJ, Sinha P, et al. Phenotypes and personalized medicine in the acute respiratory distress syndrome. Intensive Care Medicine [Internet]. 2020 Nov 18;46(12):2136–52. Available from: http://dx.doi.org/10.1007/s00134-020-06296-9

Heijnen NFL, Hagens LA, Smit MR, Cremer OL, Ong DSY, van der Poll T, et al. Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine [Internet]. 2021 Jun 15;203(12):1503–11. Available from: http://dx.doi.org/10.1164/rccm.202006-2522oc

Combes A, Schmidt M, Hodgson CL, Fan E, Ferguson ND, Fraser JF, et al. Extracorporeal life support for adults with acute respiratory distress syndrome. Intensive Care Medicine [Internet]. 2020 Nov 2;46(12):2464–76. Available from: http://dx.doi.org/10.1007/s00134-020-06290-1